Evidence map›Paper›PMID 29284440›Full record

ArticleBMC cancer2017

Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.

Chia-Hsin Chang, Wei-Ting Liu, Hui-Chi Hung, Chia-Yu Gean, Hong-Ming Tsai, Chun-Lin Su, Po-Wu Gean

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Regulations of organism by materials: a new understanding of biological inorganic chemistry.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2019
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chia-Hsin ChangDepartment of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Wei-Ting LiuDepartment of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Hui-Chi HungDepartment of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Chia-Yu GeanDepartment of Diagnostic Radiology, National Cheng Kung University Hospital, Tainan, Taiwan.
Hong-Ming TsaiDepartment of Diagnostic Radiology, National Cheng Kung University Hospital, Tainan, Taiwan.
Chun-Lin SuDepartment of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Po-Wu GeanDepartment of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. powu@mail.ncku.edu.tw.
National Cheng Kung University · TWNational Cheng Kung University Hospital · TW

Funding

Ministry of Science and Technology, Taiwan 104-2320-B-006-007-MY3National Science Council of Taiwan NSC101-2320-B-006-040-MY3
6 · The paper itself

Abstract

backgroundGlioma stem cells (GSCs) contribute to tumor recurrence and drug resistance. This study characterizes the tumorigenesis of CD133

methodsGSCs from human U87 and rat C6 glioblastoma cell lines were isolated via magnetic cell sorting using CD133 as a cancer stem cell marker. Cell proliferation was determined using the WST-1 assay. An intracranial mouse model and bioluminescence imaging were used to assess the effects of drugs on tumor growth in vivo.

resultsCD133

conclusionThe results suggest that concurrent targeting of different subpopulations of glioblastoma cells may be an effective therapeutic strategy for patients with malignant glioma.

Indexed as

Drug SynergismAC133 AntigenAnimalsAnti-Bacterial AgentsAntineoplastic AgentsApoptosisBrain NeoplasmsCell ProliferationDrug CombinationsGlioblastomaHumansMaleMice, Inbred BALB CMice, NudeMinocyclineNeoplastic Stem CellsAC133 AntigenAnti-Bacterial AgentsAntineoplastic AgentsDrug CombinationsMinocyclineSTAT3 Transcription FactorCancer stem cellsCombination therapyGliomaMinocyclineSTAT3Synergy

Identifiers

PMID29284440
PMCPMC5747127
OpenAlexW2779679501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.